AB928   Click here for help

GtoPdb Ligand ID: 11154

Synonyms: AB-928
PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: AB928 is an oral dual antagonist of the adenosine 2A and 2B receptor isoforms [4]. It was developed to counteract adenosine-mediated immune suppression in the tumour microenvironment by targeting A2AR-expressing T and NK cells and A2A/2BR-expressing myeloid cells.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 139.42
Molecular weight 426.19
XLogP 2.27
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N#Cc1cccc(c1C)c1nc(N)nc(c1)c1nnn(c1)Cc1cccc(n1)C(O)(C)C
Isomeric SMILES N#Cc1cccc(c1C)c1nc(N)nc(c1)c1nnn(c1)Cc1cccc(n1)C(O)(C)C
InChI InChI=1S/C23H22N8O/c1-14-15(11-24)6-4-8-17(14)18-10-19(28-22(25)27-18)20-13-31(30-29-20)12-16-7-5-9-21(26-16)23(2,3)32/h4-10,13,32H,12H2,1-3H3,(H2,25,27,28)
InChI Key BUXIAWLTBSXYSW-UHFFFAOYSA-N
Immunopharmacology Comments
The A2AR is recognised as a immune checkpoint with immunosuppressive function, and the adenosine/A2AR pathway is exploited by some cancers to suppress antitumour immunity. Antagonism of receptor activation aims to restore the anticancer functions of the immune cell subsets that are sensitive to adenosine. A2BR stimulation also induces immunosuppressive effects via dendritic cell-driven T helper cell 1 (Th1) responses and promotion of T cell > T regulatory phenotype transition [2-3].